HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.

AbstractOBJECTIVE:
The fused in sarcoma/translated in liposarcoma (FUS/TLS) protein was recently identified as a cause of familial amyotrophic lateral sclerosis (ALS), as well as a major component of the inclusion bodies found in subtypes of frontotemporal lobar degeneration (FTLD). These diseases now are collectively known as the novel clinical spectrum, FUS proteinopathy. ALS-linked mutations of FUS are clustered in the C-terminal region; however, the molecular properties of mutant FUS remain unclear. To gain insight into the pathogenesis of FUS proteinopathy, we examined the biochemical and cellular characteristics of mutant FUS in expressing cells.
METHODS AND RESULTS:
Expression of ALS-linked FUS mutations resulted in their assembly into cytoplasmic stress granules (SGs), cellular structures that package mRNA and RNA-binding proteins during cell stress. A deletion mutant series revealed that the C-terminal region in FUS is critical for nuclear retention via Ran guanosine triphosphatase-dependent transport machinery. A parallel study of subcellular distribution revealed that ALS-linked mutants additively disturb the function of the C-terminus for nuclear traffic, resulting in cytoplasmic accumulation and the formation of SGs.
INTERPRETATION:
This study demonstrates that mutant FUS, which is missing the nuclear traffic activity of the C-terminus, is dislocated to cytoplasm and assembled into SGs, indicating that disruption of translational regulation and metabolism of mRNA via inappropriate/excessive SGs may be crucial for FUS proteinopathies. Our findings provide new biological and pathological insights into the FUS protein that should help our understanding of the pathogenesis of ALS/FTLD.
AuthorsDaisuke Ito, Morinobu Seki, Yoshiko Tsunoda, Hidemi Uchiyama, Norihiro Suzuki
JournalAnnals of neurology (Ann Neurol) Vol. 69 Issue 1 Pg. 152-62 (Jan 2011) ISSN: 1531-8249 [Electronic] United States
PMID21280085 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 American Neurological Association.
Chemical References
  • DNA, Complementary
  • RNA, Messenger
  • RNA-Binding Protein FUS
  • RNA-Binding Proteins
Topics
  • Active Transport, Cell Nucleus (genetics, physiology)
  • Amyotrophic Lateral Sclerosis (genetics, metabolism, physiopathology)
  • Animals
  • Cells, Cultured
  • Cytoplasmic Granules (genetics, metabolism)
  • DNA, Complementary (metabolism)
  • Fluorescent Antibody Technique
  • Gene Expression Regulation
  • HeLa Cells (metabolism)
  • Humans
  • Inclusion Bodies (genetics, metabolism)
  • Mice
  • RNA, Messenger (genetics, metabolism)
  • RNA-Binding Protein FUS (genetics, physiology)
  • RNA-Binding Proteins (genetics)
  • Sequence Deletion (genetics, physiology)
  • Subcellular Fractions (metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: